Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. J Vasc Surg 2015; 61: 703–712.

Published: 20th May 2015

Authors: Lumsden AB, Morrissey NJ, Staffa R, Lindner J, Janousek L, Treska V et al.on behalf of the Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators et al.

Conclusion

A new heparin-bonded graft was compared to standard PTFE for above or below knee bypass in 209 patients. One year patency was improved for patients who had the heparin-bonded graft: 76.5 versus 67 per cent; P=0.05.

Pubmed Link

Your comments

0 Comments